CASSANDRA SIMMS: Open Payments
NPI 1437117926 · CHATTANOOGA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$516 in 25 payments from 9 companies in 2025. Trend: 2023 $799 · 2024 $826 · 2025 $516
Food & beverage: $516
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 10 | $205 |
| Corium, LLC | 7 | $137 |
| Collegium Pharmaceutical, Inc. | 2 | $36 |
| JAZZ PHARMACEUTICALS INC. | 1 | $35 |
| Alkermes, Inc. | 1 | $28 |
| Lundbeck LLC | 1 | $24 |
| Neurocrine BioSciences, Inc. | 1 | $22 |
| ABBVIE INC. | 1 | $15 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $14 |
Products named: Qelbree, Azstarys, Jornay PM, XYWAV, LYBALVI, REXULTI, INGREZZA, VRAYLAR.
Industry payments across TN — which companies pay providers there.
